Loading clinical trials...
Loading clinical trials...
Invasive Pulmonary Aspergillosis Treatment Duration of Posaconazole-initiated Antifungal Strategy in Patients with Hematological Malignancies: a Prospective, Single-center Study
Conditions
Locations
1
China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Start Date
December 1, 2024
Primary Completion Date
August 31, 2025
Completion Date
August 31, 2026
Last Updated
December 27, 2024
NCT03717623
NCT06382922
NCT07295314
NCT04486885
NCT06028451
NCT01614145
Lead Sponsor
Peking University People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions